While smoking remains the leading risk factor, other contributors include secondhand smoke, air pollution, radon exposure and ...

Amini: The systemic landscape is constantly changing and is very exciting. It will only become more complicated for our ...

(Nasdaq: BDSX), a leading diagnostics solutions company, announced the publication of the largest lung nodule biomarker clinical validation study ever conducted. This milestone strengthens the ...

Minimally invasive technology enables earlier detection and faster treatment of lung cancer Broward Health Medical Center announced the acquisition of the Ion™ Endoluminal System. This ...

bioAffinity Technologies Inc. BIAF shares are down during Thursday’s premarket session. Over the last week, the stock has ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

I heard it in several settings from family medicine clinic to a thoracic surgery operating room, from different levels of the ...

SAN ANTONIO, March 17, 2026--bioAffinity Technologies' new patient case study demonstrates the benefit of CyPath Lung in ...

bioAffinity Technologies Inc BIAF shares are trading higher on Tuesday morning. The move follows the release of a new ...

Pulmonary involvement is highly prevalent in individuals with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), affecting 82.7% of patients with granulomatosis with polyangiitis ...

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...